A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma
Clinical trial NCT01311661 · COMPLETED
Trial details
- NCT number
- NCT01311661
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-12-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.